article thumbnail

Novel uses for implanted haemodynamic monitoring in adults with subaortic right ventricles

Heart BMJ

Background Pulmonary hypertension (PH) is a common complication in patients with complete dextro-transposition of the great arteries (TGA) after atrial switch (D-TGA/AS) and congenitally corrected TGA (ccTGA). In follow-up (median 23 months), HFHs/year were similar to the year prior to IHM (median 0 (IQR 0–1.0) before vs 0 (0–0.8)

article thumbnail

Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy

Frontiers in Cardiovascular Medicine

CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. At present, the main methods to treat ischemic heart disease are drug therapy, intervention and operation. In China, the death rate of CVDs ranks the first in all major diseases.

article thumbnail

Understanding an Enlarged Heart (Cardiomegaly): Causes, Symptoms, and Treatment

MIBHS

High Blood Pressure (Hypertension) Persistent high blood pressure forces the heart to work harder to pump blood. Over time, this additional strain causes the heart muscle to thicken, enlarging the heart. Left Ventricular Assist Device (LVAD) , a mechanical pump that helps the heart pump blood more effectively.

article thumbnail

Emergency Department Use and Hospital Mortality Among Heart Transplant Recipients in the United States

Journal of the American Heart Association

Journal of the American Heart Association, Ahead of Print. BackgroundAnnual heart transplant (HT) volumes have increased, as have post‐HT outpatient care needs. days), and comorbidity burden was high: 42% had hypertension, 38% had diabetes, and 31% had ≥2 comorbidities. Length of stay was 3.1 days (interquartile range, 1.6–5.9

article thumbnail

Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure

DAIC

PROACTIVE-HF demonstrated that with Cordella clinicians achieved more optimal and timely dosing of key HF medications, significantly improving outcomes.

article thumbnail

V-Wave to Present Late-Breaking Data from Pivotal RELIEVE-HF Study at American College of Cardiology Annual Scientific Session and Expo

DAIC

The primary effectiveness endpoint was a composite of death, heart transplant/left ventricular assist device (LVAD) implantation, HF hospitalization, outpatient HF worsening, and quality of life. HFpEF is HF with preserved ejection fraction in which pressure builds up in the heart and lungs due to a stiffened left ventricle.

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Part 1: Concepts, Indicator Variables, and Controversies The Annals of Thoracic Surgery January 2022 Arman Kilic Supplementing Existing Societal Risk Models for Surgical Aortic Valve Replacement With Machine Learning for Improved Prediction Journal of the American Heart Association November 2021 Jared Belle Strategies for Mechanical Right Ventricular (..)